Earnings Call · Q3 FY2023·2024-02-08

Q3 23EPS -100.00%*·Rev n/aQ2 23EPS -100.00%*·Rev n/aQ1 23EPS +42.86%·Rev n/aQ4 22EPS -100.00%*·Rev n/a⚠ consensus missing

PETMED EXPRESS INC PETS

Brian Prenoveau — Investor Relations

Matthew Hulett — CEO

Let's turn to our operational advancements and initiatives. We have talked about our key performance indicators for the transformation of the business — Unknown

Christine Chambers — CFO

Unknown — Unknown

+1.9%1d on move date+1.3% vs SPY3d−8.7%5d−9.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PETS calls or request research access.

More PETS calls Browse calls Request research access